Authors:
BLACK SB
SHINEFIELD HR
BERGEN R
HART C
KREMERS R
LAVETTER A
LEMESURIER J
MOROZUMI PA
RAY P
LEWIS EM
FIREMAN B
SCHWALBE J
HALLAM P
SHANDLING M
DEKKER C
GRANOFF DM
IZU A
PODDA A
Citation: Sb. Black et al., SAFETY AND IMMUNOGENICITY OF CHIRON BIOCINE(R) RECOMBINANT ACELLULAR PERTUSSIS-DIPHTHERIA-TETANUS VACCINE IN INFANTS AND TODDLERS/, The Pediatric infectious disease journal, 16(1), 1997, pp. 53-58
Authors:
RAY P
BLACK S
SHINEFIELD H
DILLON A
SCHWALBE J
HOLMES S
HADLER S
CHEN R
COCHI S
WASSILAK S
Citation: P. Ray et al., RISK OF CHRONIC ARTHROPATHY AMONG WOMEN AFTER RUBELLA VACCINATION, JAMA, the journal of the American Medical Association, 278(7), 1997, pp. 551-556
Authors:
DAVIS RL
MARCUSE E
BLACK S
SHINEFIELD H
GIVENS B
SCHWALBE J
RAY P
THOMPSON RS
CHEN R
GLASSER JW
RHODES PH
SWINT E
JACKSON LA
BARLOW WE
IMMANUEL VH
BENSON PJ
MULLOOLY JP
DREW L
MENDIUS B
LEWIS N
FIREMAN BH
WARD JI
VADHEIM CM
MARCY SM
JING J
WULFSON M
LUGG M
OSBORNE P
WISE RP
RASTOGI S
PATRIARCA P
CASERTA V
Citation: Rl. Davis et al., MMR2 IMMUNIZATION AT 4 TO 5 YEARS AND 10 TO 12 YEARS OF AGE - A COMPARISON OF ADVERSE CLINICAL EVENTS AFTER IMMUNIZATION IN THE VACCINE SAFETY DATALINK PROJECT, Pediatrics, 100(5), 1997, pp. 767-771